Cargando…

Association between common polymorphisms in ERCC gene and prognosis of osteosarcoma in patients treated with chemotherapy: a meta-analysis

PURPOSE: Some previous studies have sought to investigate the roles of excision repair cross complementation group 1 (ERCC1), ERCC2, ERCC4, and ERCC5 gene polymorphisms in the prognosis of osteosarcoma patients. However, their results were inconclusive. Here, we performed a meta-analysis to determin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Chunpu, Yu, Xin, Guo, Dongmei, Liu, Guanhua, Zhang, Kaigang, Teng, Qingliang, Lin, Hai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6011878/ https://www.ncbi.nlm.nih.gov/pubmed/29950854 http://dx.doi.org/10.2147/OTT.S158167

Ejemplares similares

Meta-analysis showing that ERCC1 polymorphism is predictive of osteosarcoma prognosis
por: Liu, Xueyong, et al.
Publicado: (2017)

Genetic polymorphisms of ERCC-1 and ERCC-2 are not prognostic markers in osteosarcoma patients with chemotherapy: A meta-analysis in Chinese population
por: Liu, Dabiao, et al.
Publicado: (2018)

Genetic polymorphisms in ERCC1 and ERCC2 genes are associated with response to chemotherapy in osteosarcoma patients among Chinese population: a meta-analysis
por: Zhang, Haiguang, et al.
Publicado: (2017)

Association of ERCC gene polymorphism with osteosarcoma risk
por: Wang, Guanliang, et al.
Publicado: (2020)

Identification of key gene modules and hub genes of human mantle cell lymphoma by coexpression network analysis
por: Guo, Dongmei, et al.
Publicado: (2020)

Association between GSTP1 polymorphisms and prognosis of osteosarcoma in patients treated with chemotherapy: a meta-analysis
por: Pu, Feifei, et al.
Publicado: (2015)

ERCC1 and telomere status in breast tumours treated with neoadjuvant chemotherapy and their association with patient prognosis
por: Gay‐Bellile, Mathilde, et al.
Publicado: (2016)

Analysis of ERCC1 and ERCC2 gene variants in osteosarcoma, colorectal and breast cancer
por: GÓMEZ-DÍAZ, BENJAMÍN, et al.
Publicado: (2015)

ERCC1 polymorphisms as prognostic markers in T4 breast cancer patients treated with platinum-based chemotherapy
por: Palomba, Grazia, et al.
Publicado: (2014)

Polymorphisms in ERCC2 and ERCC5 and Risk of Prostate Cancer: A Meta-Analysis and Systematic Review
por: Liu, Yi, et al.
Publicado: (2018)

Predictive role of Glutathione S-transferases (GSTs) on the prognosis of osteosarcoma patients treated with chemotherapy
por: Teng, Jia-wen, et al.
Publicado: (2013)

The effect of ERCC1 and ERCC2 gene polymorphysims on response to cisplatin based therapy in osteosarcoma patients
por: Obiedat, Hadeel, et al.
Publicado: (2018)

Association between common polymorphisms in ERCC gene and glioma risk: A meta-analysis of 15 studies
por: Qian, Tengda, et al.
Publicado: (2017)

A common polymorphism in the 5′ UTR of ERCC5 creates an upstream ORF that confers resistance to platinum-based chemotherapy
por: Somers, Joanna, et al.
Publicado: (2015)

Polymorphisms in ERCC4 and ERCC5 and risk of cancers: Systematic research synopsis, meta-analysis, and epidemiological evidence
por: Zuo, Chunjian, et al.
Publicado: (2022)

Association of ERCC1 C8092A and ERCC2 Lys751Gln Polymorphisms with the Risk of Glioma: A Meta-Analysis
por: Xin, Yu, et al.
Publicado: (2014)

Association of ERCC1 rs3212986 & ERCC2 rs13181 polymorphisms with the risk of glioma
por: Cui, Qing-ke, et al.
Publicado: (2014)

Association between the ERCC1 polymorphism and platinum-based chemotherapy effectiveness in ovarian cancer: a meta-analysis
por: Tang, Ning, et al.
Publicado: (2017)

ERCC1 and the Prognosis for Patients With Colon Cancer Receiving Oxaliplatin-Based Adjuvant Chemotherapy
por: Baek, Moo-Jun
Publicado: (2015)

The Association of ERCC1 and ERCC5 Polymorphisms with Lung Cancer Risk in Han Chinese
por: Lan, Xueling, et al.
Publicado: (2022)

Association of ERCC1 and ERCC2 polymorphisms with colorectal cancer risk in a Chinese population
por: Ni, Min, et al.
Publicado: (2014)

The expression of ERCC1 and BRCA1 predicts prognosis of platinum-based chemotherapy in urothelial cancer
por: Song, Wenhui, et al.
Publicado: (2016)

Effect of ERCC1 polymorphisms on the response to platinum-based chemotherapy: A systematic review and meta-analysis based on Asian population
por: Wu, Xiaoqing, et al.
Publicado: (2023)

A miR‐15a related polymorphism affects NSCLC prognosis via altering ERCC1 repair to platinum‐based chemotherapy
por: Xue, Ping, et al.
Publicado: (2022)

Associations of individual and joint expressions of ERCC6 and ERCC8 with clinicopathological parameters and prognosis of gastric cancer
por: Chen, Jing, et al.
Publicado: (2021)

Association of ERCC5 Genetic Polymorphisms With Cirrhosis and Liver Cancer
por: Yang, Gang, et al.
Publicado: (2020)

Association between the ERCC1 rs11615 polymorphism and clinical outcomes of oxaliplatin-based chemotherapies in gastrointestinal cancer: a meta-analysis
por: Ma, Shou-Cheng, et al.
Publicado: (2015)

Chinese C allele carriers of the ERCC5 rs1047768 polymorphism are more sensitive to platinum-based chemotherapy: a meta-analysis
por: Xu, Meizhen, et al.
Publicado: (2017)

ERCC1 and XRCC1 but not XPA single nucleotide polymorphisms correlate with response to chemotherapy in endometrial carcinoma
por: Chen, Liang, et al.
Publicado: (2016)

Prevalence of CTR1 and ERCC1 Polymorphisms and Response of Biliary Tract Cancer to Gemcitabine-Platinum Chemotherapy
por: Pongmaneratanakul, Skolchart, et al.
Publicado: (2017)

ERCC1, XRCC1, and GSTP1 Polymorphisms and Treatment Outcomes of Advanced Epithelial Ovarian Cancer Patients Treated with Platinum-based Chemotherapy
por: Liblab, Salisa, et al.
Publicado: (2020)

Polymorphisms in ERCC5 rs17655 and ERCC1 rs735482 Genes Associated with the Survival of Male Patients with Postoperative Oral Squamous Cell Carcinoma Treated with Adjuvant Concurrent Chemoradiotherapy
por: Senghore, Thomas, et al.
Publicado: (2019)

Association of ERCC1 rs11615 Polymorphism with the Risk of Cervical Cancer Especially in Chinese Populations: A Meta-Analysis
por: Zhang, Yufeng, et al.
Publicado: (2022)

Polymorphisms in ERCC1, GSTs, TS and MTHFR predict clinical outcomes of gastric cancer patients treated with platinum/5-Fu-based chemotherapy: a systematic review
por: Wang, Zhen, et al.
Publicado: (2012)

Association between the ERCC5 Asp1104His Polymorphism and Cancer Risk: A Meta-Analysis
por: Zhu, Mei-Ling, et al.
Publicado: (2012)

Correlation of ERCC5 polymorphisms and linkage disequilibrium associated with overall survival and clinical outcome to chemotherapy in breast cancer
por: Khan, Iqra, et al.
Publicado: (2023)

A Comprehensive Evaluation of the Association between Polymorphisms in XRCC1, ERCC2, and XRCC3 and Prognosis in Hepatocellular Carcinoma: A Meta-Analysis
por: Zhao, Yan, et al.
Publicado: (2019)

ERCC1 Expression in Metastatic Triple Negative Breast Cancer Patients Treated with Platinum-Based Chemotherapy
por: Baiomy, Mohamed Ali EL, et al.
Publicado: (2017)

Polymorphisms in XPD and ERCC1 Associated with Colorectal Cancer Outcome
por: Huang, Ming-Yii, et al.
Publicado: (2013)

The role of ERCC1 and AFP gene polymorphism in hepatocellular carcinoma
por: Huang, Yu-Liang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_v8ukd5pt5sl0m29554t3cqt31l